Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

被引：0
|
作者：
Shahin Akhondzadeh
Raofeh Ghayyoumi
Farzin Rezaei
Bahman Salehi
Amir-Hossein Modabbernia
Azad Maroufi
Gholam-Reza Esfandiari
Mehrangiz Naderi
Fariba Ghebleh
Mina Tabrizi
Shams-Ali Rezazadeh
机构：
[1] Tehran University of Medical Sciences,Psychiatric Research Center, Roozbeh Psychiatric Hospital
[2] Kurdistan University of Medical Sciences,Qods Hospital
[3] Arak University of Medical Sciences,Shaheed Hashemi Senejani Hospital
[4] Tehran University of Medical Sciences,Department of Medical Genetics, Faculty of Medicine
[5] Institute of Medicinal Plants (ACECR),undefined
来源：
Psychopharmacology | 2011年 / 213卷
关键词：
Adjunctive therapy; Sildenafil; Negative symptoms; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：809 / 815
页数：6
相关论文
共 50 条
  • [1] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Ghayyoumi, Raofeh
    Rezaei, Farzin
    Salehi, Bahman
    Modabbernia, Amir-Hossein
    Maroufi, Azad
    Esfandiari, Gholam-Reza
    Naderi, Mehrangiz
    Ghebleh, Fariba
    Tabrizi, Mina
    Rezazadeh, Shams-Ali
    PSYCHOPHARMACOLOGY, 2011, 213 (04) : 809 - 815
  • [2] Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled trial
    Akhondzadeh, Shahin
    Bayanati, Samaneh
    Mozen-Zadeh, Ehsan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1206 - 1206
  • [3] Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study
    Rezaei, Farzin
    Mesgarpour, Bita
    Jeddian, Alireza
    Zeionoddini, Atefeh
    Mohammadinejad, Payam
    Salardini, Elaheh
    Shahriari, Mona
    Zeinoddini, Arefeh
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (04)
  • [4] Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial
    Shamabadi, Ahmad
    Rafiei-Tabatabaei, Elham-Sadat
    Kazemzadeh, Kimia
    Farahmand, Kimia
    Fallahpour, Bita
    Ardakani, Mohammad-Reza Khodaei
    Akhondzadeh, Shahin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 (01):
  • [5] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, Shahin
    Tabatabaee, Maryam
    Amini, Homayoun
    Abhari, Seyed Ali Ahmadi
    Abbasi, Seyed Hesamedin
    Behnam, Behnaz
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
  • [6] Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Moazen-Zadeh, Ehsan
    Shirzad, Fatemeh
    Karkhaneh-Yousefi, Mohammad-Ali
    Khezri, Rasoul
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 82 - 89
  • [7] Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
    Amiri, Afshar
    Noorbala, Ahmad-Ali
    Neiatisafa, Ali-Akbar
    Ghoreishi, Abolfazl
    Derakhshan, Mohammad-Kamran
    Khodaie-Ardakani, Mohammad-Reza
    Hajiazim, Mohammad
    Raznahan, Maedeh
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (02) : 79 - 86
  • [8] A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia
    Pierre, Joseph M.
    Peloian, John H.
    Wirshing, Donna A.
    Wirshing, William C.
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 705 - 710
  • [9] Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial
    Tajik-Esmaeeli, Soode
    Moazen-Zadeh, Ehsan
    Abbasi, Niloofar
    Shariat, Seyed V.
    Rezaei, Farzin
    Salehi, Bahman
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 87 - 94
  • [10] Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial
    Hosseini, Seyed Mohammad Reza
    Farokhnia, Mehdi
    Rezaei, Farzin
    Gougol, Amirhossein
    Yekehtaz, Habibeh
    Iranpour, Negar
    Salehi, Bahman
    Tabrizi, Mina
    Tajdini, Masih
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (06) : 846 - 855
12345